JSM Preliminary Online Program
This is the preliminary program for the 2009 Joint Statistical Meetings in Washington, DC.

The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.


Back to main JSM 2009 Program page




Activity Number: 361
Type: Topic Contributed
Date/Time: Tuesday, August 4, 2009 : 2:00 PM to 3:50 PM
Sponsor: Section on Statistics in Epidemiology
Abstract - #304178
Title: When is a Diagnostic Test Informative?
Author(s): Lakshmi Vishnuvajjala*+
Companies: FDA
Address: 1350 Piccard Drive, HFZ-550, Rockville, MD, 20850,
Keywords: Diagnostic ; Test ; Informative ; Prevalence ; False positive ; False negative
Abstract:

For a diagnostic test to be informative, it needs to identify a greater proportion of patients with the condition as positive compared to the proportion of patients without the condition. All the performance measures deal with when a test is informative statistically. Does all this necessarily translate into being informative in the clinical sense? For a test with 99% sensitivity and 61% specificity, the sum is 160%; it is also 160% for a test with 80% sensitivity and 80% specificity. Are both the tests equally informative? What role does prevalence play? Ultimately, the usefulness of the test depends on the consequences of false positives and false negatives. These issues will be discussed with illustrative examples.


  • The address information is for the authors that have a + after their name.
  • Authors who are presenting talks have a * after their name.

Back to the full JSM 2009 program


JSM 2009 For information, contact jsm@amstat.org or phone (888) 231-3473. If you have questions about the Continuing Education program, please contact the Education Department.
Revised September, 2008